Simon Peter Cooper - Aug 2, 2021 Form 3 Insider Report for Keros Therapeutics, Inc. (KROS)

Role: Chief Medical Officer
Signature: /s/ Keith Regnante, Attorney-in-Fact
Stock symbol: KROS
Transactions as of: Aug 2, 2021
Transactions value $: $0
Form type: 3
Date filed: 8/11/2021, 04:54 PM
Next filing: Aug 11, 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney